Stocks · Health care · Pharmaceutical Preparations

MADRIGAL PHARMACEUTICALS, INC.

MDGL Clue Score55
United States Fiscal year ends December CIK 0001157601 Results filed 3 Nov 2026

What the insiders did Net selling

By person

23 insiders · 766 transactions
117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Fred B Craves
Director
$249.39K (3)
$222.54M (34)
−$222.29M
361,076
1.56%
$197.28M
−94.3%
Bay City Capital LLC entity
10% owner
—
$210.34M (7)
−$210.34M
1,261
0.0055%
$688.98K
−100.0%
Paul A Friedman
Director
$967.52K (2)
$147.39M (105) scheduled
−$146.42M
842,704
3.65%
$460.43M
−4.5%
Baker Bros. Advisors LP entity
Director
$139.67M (192)
—
+$139.67M
1,948,876
8.44%
$1.06B
+45.3%
Rebecca Taub
Director
—
$89.31M (92) scheduled
−$89.31M
1,108,207
4.80%
$605.50M
+9.0%
Kenneth Bate
Director
—
$27.02M (43) scheduled
−$27.02M
2,627
0.0114%
$1.44M
—
Richard S Levy
Director
$145.80K (20)
$20.04M (47) scheduled
−$19.89M
22,469
0.0973%
$12.28M
—
William John Sibold
President and CEO
—
$18.86M (42)
−$18.86M
197,746
0.8559%
$108.04M
—
James M Daly
Director
—
$13.59M (19) scheduled
−$13.59M
3,081
0.0133%
$1.68M
—
Robert E. Waltermire
Senior VP, Chief Pharma Dev.
—
$11.25M (30) scheduled
−$11.25M
5,789
0.0251%
$3.16M
—
Remy Sukhija
Chief Commercial Officer
—
$8.22M (18) scheduled
−$8.22M
15,001
0.0649%
$8.20M
—
Brian Joseph Lynch
SVP and General Counsel
—
$7.63M (32) scheduled
−$7.63M
17,691
0.0766%
$9.67M
—
Mardi Dier
EVP and CFO
—
$4.49M (31) scheduled
−$4.49M
12,490
0.0541%
$6.82M
+40.7%
David Milligan V
Director
—
$3.57M (2)
−$3.57M
0
0.0000%
$0.00
—
Marc R Schneebaum
Chief Financial Officer
—
$2.90M (1) scheduled
−$2.90M
41,668
0.1803%
$22.77M
−4.9%
Carole Huntsman
Chief Commercial Officer
—
$2.65M (25) scheduled
−$2.65M
12,692
0.0549%
$6.93M
—
Shannon T Kelley
General Counsel
—
$1.54M (14) scheduled
−$1.54M
11,474
0.0497%
$6.27M
+314.7%
David Soergel
Chief Medical Officer
—
$951.98K (2) scheduled
−$951.98K
10,033
0.0434%
$5.48M
—
Alex G. Howarth
Chief Financial Officer
—
—
—
18,737
0.0811%
$10.24M
—
Rita Thakkar
Chief Accounting Officer
—
—
—
2,398
0.0104%
$1.31M
—
Jacqualyn A Fouse
Director
—
—
—
1,551
0.0067%
$847.43K
—
Daniel J. Brennan
Director
—
—
—
1,371
0.0059%
$749.08K
—
John C Reed
Director
—
—
—
647
0.0028%
$353.51K
—